Clinical Trial: Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension
Study Status: Completed
Recruit Status: RECRUITING
Condition: Hypertension
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension
Brief Summary:
This is a Phase 3 trial to evaluate the BP-lowering effect of lorundrostat (an aldosterone synthase inhibitor) in subjects with uncontrolled and resistant hypertension taking between 2 and 5 anti-hypertensive (AHT) medications.
Read more